Cargando…
Oncogenes in immune cells as potential therapeutic targets
The role of deregulated expression of oncogenes and tumor-suppressor genes in tumor development has been intensively investigated for decades. However, expression of oncogenes and their potential role in immune cell defects during carcinogenesis and tumor progression have not been thoroughly assesse...
Autores principales: | Zakiryanova, Gulnur K, Wheeler, Sarah, Shurin, Michael R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903485/ https://www.ncbi.nlm.nih.gov/pubmed/29692982 http://dx.doi.org/10.2147/ITT.S150586 |
Ejemplares similares
-
Abnormal Expression of c-Myc Oncogene in NK Cells in Patients with Cancer
por: Zakiryanova, Gulnur K., et al.
Publicado: (2019) -
Alterations of oncogenes expression in NK cells in patients with cancer
por: Zakiryanova, Gulnur K., et al.
Publicado: (2017) -
Phosphoglycerate Dehydrogenase: Potential Therapeutic Target and Putative Metabolic Oncogene
por: Zogg, Cheryl K.
Publicado: (2014) -
Oncosuppressors and Oncogenes: Role in Haemangioma Genesis and Potential for Therapeutic Targeting
por: Mabeta, Peace
Publicado: (2018) -
RNF6 as an Oncogene and Potential Therapeutic Target—A Review
por: Zapolnik, Paweł, et al.
Publicado: (2020)